Skip to main content

Table 2 Reports describing the association of MN and sarcoidosis

From: The co-occurrence of sarcoidosis and anti-PLA2R-associated membranous nephropathy in a patient with underlying genetic susceptibility

Year

Reference

Age

/Gender

Clinical/laboratory features

Renal pathology

Sequence of onset of sarcoidosis and MN

PLA2R Ab

Therapy

Outcome

1978

Mariani AF et al. (14)

25/F 19/M

NS

MN

Sarcoidosis preceded the onset of MN by 6 months in the 25-year-old female patient and presented simultaneously with MN in the 19-year-old male patient.

NA

prednisone, CTX

resolution of proteinuria, stabilization of renal function

1979

Talyor TK et al. (15)

57/M

NS,

elevated Scr

MN with epithelial crescents

Sarcoidosis preceded the onset of MN by 10 years with progression of sarcoidosis.

NA

NA

NA

1989

Jones B et al. (16)

32/F

proteinuria

MN

Sarcoidosis preceded the onset of MN by 5 years and recurred at the onset of MN.

NA

prednisone

resolution of proteinuria, relapse after ceasing prednisone

1994

Khan IH et al. (17)

56/F

NS

MN and granulomatous interstitial nephritis

Simultaneously

NA

prednisone

decrease in proteinuria, stabilization of renal function

1999

Toda T et al. (18)

49/F

Hypercalcemia, elevated Scr

MN and interstitial nephritis

Simultaneously

NA

prednisone

recovery of renal function and hypercalcemia

1999

Dimitriades C et al. (19)

13/F

NS

MN

Sarcoidosis preceded the onset of MN by 1 year, and recurred at the onset of MN.

NA

prednisone, CTX

stabilization of sarcoidosis, resolution of proteinuria, normal renal function

2011

Knehtl M et al. (20)

29/M

NS

MN and granulomatous tubulointerstitial nephritis

MN preceded the onset of sarcoidosis by 5 months.

seropositive for anti-PLA2R Ab and positive for PLA2R in renal biopsy

prednisone

resolution of nephrotic syndrome, stabilization of renal function

2013

Stehle T et al. (5,10)

Total of 11 patients, 3 females and 8 males

seven of the 11 patients were NS

MN, 2 with GTIN

Three patients exhibited glomerular lesions simultaneously with sarcoidosis. MN preceded the onset of sarcoidosis in 5 patients (mean delay of 4.5 years). In 3 other patients, MN was diagnosed after sarcoidosis (mean delay of 12.6 years).

data available for 9 patients: 3 seropositive for anti-PLA2R Ab, 5 positive for PLA2R on renal biopsy

supportive care in 5 patients,

prednisone in 6 patients

2 patients progressed to ESRD, and 1 patient died.

  1. Note: CTX, cyclophosphamide; ESRD, end-stage renal disease; GTIN, granulomatous tubulointerstitial nephritis; NS, nephrotic syndrome; MN, membranous nephropathy; NA, not applicable; PLA2R, phospholipase A2 receptor